Dr. Tim Sellati, the former Chief Scientific Officer at Global Lyme Alliance, emphasized the urgent need to rethink how we identify and diagnose chronic Lyme patients to improve clinical trials. His presentation at the latest NASEM meeting also highlighted the potential of composite diagnostic testing, the GLA process and approach to funding research, and the need to bridge the gap in knowledge and understanding.
***